the role of daratumumab in the treatment of myeloma and insights into the maia trial
Published 1 year ago • 111 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
5:07
daratumumab in the management of al amyloidosis
-
1:58
treatment options for patients with multiple myeloma who are resistant to daratumumab
-
0:52
the future of daratumumab in multiple myeloma
-
0:54
the experience of single-agent daratumumab for r/r myeloma in india
-
2:37
updated analysis of the maia trial: long-term safety and efficacy data
-
2:04
a novel mechanism of action for daratumumab in myeloma
-
2:00
daratumumab in the treatment of heavily pretreated immune-mediated ttp
-
2:41
optimizing the use of daratumumab in al amyloidosis
-
4:01
choosing between isatuximab & daratumumab in multiple myeloma
-
2:38
how close is a cure for multiple myeloma?
-
7:32
long-term efficacy of daratumumab-based regimen in multiple myeloma
-
3:51
daratumumab in multiple myeloma: an overview of 3 key trials
-
2:08
an insight into the current understanding of risk factors for cll
-
3:24
results from the breselibet trial of brentuximab vedotin chemotherapy for r/r hodgkin lymphoma
-
2:09
assessing the role of daratumumab in all
-
1:28
the apollo trial: daratumumab for r/r myeloma
-
3:27
case study: daratumumab in a relapsed patient
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
1:05
an overview of the radar trial
-
1:34
checkpoint inhibitors and their potential role in mm
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma